A new study shows that gene therapy can significantly improve hearing in both children and adults with congenital deafness caused by mutations in the OTOF gene. The therapy uses a synthetic virus to deliver a healthy copy of the gene directly to the inner ear, with hearing improvements observed in all ten participants within one month.
A new study shows that gene therapy can significantly improve hearing in both children and adults with congenital deafness caused by mutations in the OTOF gene. The therapy uses a synthetic virus to deliver a healthy copy of the gene directly to the inner ear, with hearing improvements observed in all ten participants within one month.
Share this Article
Recommended